Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statistical methodology for screening studies with qualitative/quantitative mixtures

R A DeMasi1, D Quade, C F Shih

  • 1Glaxo Wellcome, Inc., Research Triangle Park, North Carolina 27709, USA.

Journal of Biopharmaceutical Statistics
|April 21, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcome.

Advances in therapy·2001
Same author

Health-related quality of life and virologic outcomes in an HIV clinic.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2001
Same author

Empirical power for distribution-free tests of incomplete longitudinal data with applications to AIDS clinical trials.

Journal of biopharmaceutical statistics·1999
Same author

Barriers to the use of preventive health care services for children.

Public health reports (Washington, D.C. : 1974)·1996
Same author

Diversity in the rural poor: differences between households with and without telephones.

Public health nursing (Boston, Mass.)·1995
Same author

Health outcomes of children receiving EPSDT checkups: a pilot study.

Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners·1995
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

A new statistical method aids in designing screening studies for experimental treatments, identifying promising candidates for further biopharmaceutical research. This approach optimizes the selection process for future clinical trials.

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Pharmaceutical Research

Background:

  • Screening studies are crucial in biopharmaceutical R&D to identify promising treatments.
  • Phase II clinical trials aim to select effective drug regimens for Phase III development.
  • Existing methods may not fully address the complexities of qualitative/quantitative efficacy data.

Purpose of the Study:

  • To develop a statistical method for designing effective screening studies.
  • To identify the most promising experimental treatments compared to a standard.
  • To aid in the selection of treatments for subsequent rigorous evaluation.

Main Methods:

  • Development of a statistical methodology for comparative screening studies.
  • Assumption of a qualitative/quantitative mixture distribution for efficacy variables.

Related Experiment Videos

  • Calculation of acceptance probabilities for experimental treatments versus a standard.
  • Utilizing operating characteristic contour plots for visualization.

    • Main Results:

    • The method provides a framework for evaluating experimental treatments in screening studies.
    • Operating characteristic contour plots visualize the probability of accepting treatments.
    • The approach is applicable to situations with mixed-type efficacy data.

    Conclusions:

    • The proposed statistical method enhances the design of screening studies in biopharmaceutical research.
    • It offers a robust approach for identifying promising treatments based on mixed efficacy data.
    • This methodology can improve the efficiency of drug development pipelines.